SIRT2 and cancer: The inhibition of Sirt2 is associated with promising neuroprotective, anticarcinogenic, and anti-inflammatory effects; therefore, the development of highly potent and selective inhibitors of this subtype provides an important contribution to the understanding and treatment of diseases such as cancer, Alzheimer’s disease, Huntington’s disease, and Parkinson’s disease [8,9,10,11,12].